Influence on the prognosis of misuse of antibiotics prior to admission in patients with community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Significance of comorbidity in elderly patients with community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 3s Year: 2006
The general evaluation of elderly patients with community acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 412s Year: 2004
Consequences of community acquired pneumonia requiring admission to hospital in childhood Source: Eur Respir J 2004; 24: Suppl. 48, 171s Year: 2004
Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004
Factors on admission influencing site-of-care decision for patients hospitalised for community acquired pneumonia Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010
The general evaluation of community acquired pneumonia patients treated in our clinic Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004
Frequency of cardiovascular events in hospitalised patients with community acquired pneumonia Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009
Influence of statin therapy on clinical symptoms, severity and prognosis in patients with community acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008
Determinants of hospital costs in community acquired pneumonia Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012
Clinical characteristics and antibiotic prescribing in patients admitted with community acquired pneumonia to a university hospital in Pakistan Source: Eur Respir J 2004; 24: Suppl. 48, 242s Year: 2004
COVID-19: pneumonia and comorbidities at three sites of medical care Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19 Year: 2021
Using roncoleukine in basic therapy of patients with community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002
A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia Source: Eur Respir J 2001; 18: 362-368 Year: 2001
Diagnosis and management of community acquired pneumonia in adults Source: Virtual Congress 2020 – Clinical grand round: revisiting current guidelines Year: 2020
Prevalence of nosocomial pneumonia in patients of the general surgical departments Source: Eur Respir J 2003; 22: Suppl. 45, 335s Year: 2003
The usage of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005
Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Clinical presentation and evolution of community acquired pneumonia in older patients Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012
Risk factors of treatment failure of community acquired pneumonia in patients with COPD Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008